SCHEMBL19908932

SCHEMBL19908932

Cc1ccc2c3ccc(C)cc3n(-c3cc(-c4ccncc4)c(-n4c5cc(C)ccc5c5ccc(C)cc54)cc3C#N)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 4/20 0.40
PDE3A Q14432 4/20 0.40
LMNA P02545 3/20 0.40
KDM4E B2RXH2 3/20 0.40
CYP2C19 P33261 2/20 0.40
PDE5A O76074 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
PTGS1 P23219 1/20 0.40
PDE4A P27815 1/20 0.40
BLM P54132 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19908931 0.95 ALDH1A1 (0.40) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19919533 0.92 LMNA (0.38) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19909264 0.91 PDE3B (0.41) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19913104 0.90 XDH (0.35) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19908935 0.90 PDE3B (0.40) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19909013 0.90 MEN1 (0.38) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19913128 0.89 MAPK14 (0.41) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL19908934 0.88 ALDH1A1 (0.43) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL20923446 0.88 KDM4E (0.45) PDE3BPDE3ALMNAKDM4ECYP2C19
SCHEMBL20923128 0.88 KDM4E (0.43) PDE3BPDE3ALMNAKDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 PDE3B 1366/4885PDE3A 1793/4885LMNA 3815/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 PDE3B 1366/4885PDE3A 1793/4885LMNA 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.